相似文献
1
Tamoxifen-induced endometrial carcinoma after a lag of 14 years.
South Asian J Cancer. 2013 Jan;2(1):6. doi: 10.4103/2278-330X.105867.
2
Endometrial carcinoma associated with breast carcinoma: low incidence with tamoxifen use.
Cancer. 1996 May 15;77(10):2058-63. doi: 10.1002/(SICI)1097-0142(19960515)77:10<2058::AID-CNCR14>3.0.CO;2-U.
3
Endometrial carcinoma and tamoxifen: clearing up a controversy.
Clin Cancer Res. 1995 May;1(5):467-72.
4
Screening by ultrasonography for endometrial carcinoma in postmenopausal breast cancer patients under adjuvant tamoxifen.
Gynecol Oncol. 1996 Mar;60(3):409-11. doi: 10.1006/gyno.1996.0064.
5
The incidence of subsequent endometrial carcinoma with tamoxifen use in patients with primary breast carcinoma.
Cancer. 1998 May 1;82(9):1698-703.
6
Uterine serous carcinoma and endometrial intraepithelial carcinoma arising in endometrial polyps: report of 5 cases, including 2 associated with tamoxifen therapy.
Hum Pathol. 2003 Sep;34(9):939-43. doi: 10.1016/s0046-8177(03)00335-6.
7
Risk factors of endometrial polyps resected from postmenopausal patients with breast carcinoma treated with tamoxifen.
Cancer. 2001 Sep 1;92(5):1151-5. doi: 10.1002/1097-0142(20010901)92:5<1151::aid-cncr1433>3.0.co;2-y.
8
[Tamoxifen and endometrial pathology].
Rev Med Chir Soc Med Nat Iasi. 2010 Oct-Dec;114(4):1114-7.
9
High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients.
J Clin Oncol. 1993 Mar;11(3):485-90. doi: 10.1200/JCO.1993.11.3.485.
10
Relationship between tamoxifen use and high risk endometrial cancer histologic types.
Gynecol Oncol. 2009 Jan;112(1):150-4. doi: 10.1016/j.ygyno.2008.08.035. Epub 2008 Oct 19.
引用本文的文献
1
BioMOF-Based Anti-Cancer Drug Delivery Systems.
Nanomaterials (Basel). 2023 Mar 6;13(5):953. doi: 10.3390/nano13050953.
2
Recurrence of endometrial cancer in a hysterectomised patient treated with tamoxifen for breast cancer: a case report.
J R Soc Med. 2020 Nov;113(11):454-456. doi: 10.1177/0141076820961087. Epub 2020 Oct 12.
本文引用的文献
1
Surveillance for endometrial cancer in women receiving tamoxifen.
Ann Intern Med. 1999 Jul 20;131(2):127-35. doi: 10.7326/0003-4819-131-2-199907200-00009.
2
Tamoxifen and endometrial neoplasia.
Clin Obstet Gynecol. 1996 Sep;39(3):629-40. doi: 10.1097/00003081-199609000-00012.
3
Stimulation of endometrial cancer cell growth by tamoxifen is associated with increased insulin-like growth factor (IGF)-I induced tyrosine phosphorylation and reduction in IGF binding proteins.
Endocrinology. 1996 Mar;137(3):1089-95. doi: 10.1210/endo.137.3.8603578.
Zotero 插件